dr. martens plc - DOCMF

DOCMF

Close Chg Chg %
0.99 -0.03 -2.83%

Closed Market

0.97

-0.03 (2.83%)

Volume: 42.23K

Last Updated:

Jun 3, 2026, 10:30 AM EDT

Company Overview: dr. martens plc - DOCMF

DOCMF Key Data

Open

$0.95

Day Range

0.95 - 0.97

52 Week Range

0.81 - 1.36

Market Cap

$966.66M

Shares Outstanding

957.09M

Public Float

559.74M

Beta

0.92

Rev. Per Employee

N/A

P/E Ratio

30.36

EPS

N/A

Yield

328.39%

Dividend

$0.02

EX-DIVIDEND DATE

Aug 28, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

23.83K

 

DOCMF Performance

1 Week
 
0.00%
 
1 Month
 
11.99%
 
3 Months
 
17.85%
 
1 Year
 
25.91%
 
5 Years
 
N/A
 

DOCMF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About dr. martens plc - DOCMF

Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.

DOCMF At a Glance

Dr. Martens Plc
28 Jamestown Road
London, Greater London NW1 7BY
Phone 44-121-415-7047 Revenue 1.03B
Industry Apparel/Footwear Net Income 31.89M
Sector Consumer Non-Durables 2026 Sales Growth 2.021%
Fiscal Year-end 03 / 2027 Employees 2,377
View SEC Filings

DOCMF Valuation

P/E Current 30.363
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 24.86
Price to Sales Ratio 0.786
Price to Book Ratio 1.651
Price to Cash Flow Ratio 4.79
Enterprise Value to EBITDA 5.554
Enterprise Value to Sales 1.058
Total Debt to Enterprise Value 0.476

DOCMF Efficiency

Revenue/Employee 431,227.122
Income Per Employee 13,417.709
Receivables Turnover 11.265
Total Asset Turnover 0.889

DOCMF Liquidity

Current Ratio 2.609
Quick Ratio 1.603
Cash Ratio 1.128

DOCMF Profitability

Gross Margin 57.171
Operating Margin 10.067
Pretax Margin 4.275
Net Margin 3.112
Return on Assets 2.767
Return on Equity 6.717
Return on Total Capital 3.212
Return on Invested Capital 3.417

DOCMF Capital Structure

Total Debt to Total Equity 108.271
Total Debt to Total Capital 51.986
Total Debt to Total Assets 44.614
Long-Term Debt to Equity 96.072
Long-Term Debt to Total Capital 46.128
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Dr. Martens Plc - DOCMF

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
1.20B 1.10B 1.00B 1.03B
Sales Growth
-2.94% -8.51% -8.80% +2.02%
Cost of Goods Sold (COGS) incl D&A
525.32M 470.00M 444.70M 439.01M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
65.24M 90.81M 92.74M 92.06M
Depreciation
55.13M 83.53M 84.96M 83.62M
Amortization of Intangibles
10.11M 7.28M 7.78M 8.44M
COGS Growth
+5.02% -10.53% -5.38% -1.28%
Gross Income
678.80M 631.65M 560.02M 586.02M
Gross Income Growth
-8.33% -6.95% -11.34% +4.64%
Gross Profit Margin
+56.37% +57.34% +55.74% +57.17%
2023 2024 2025 2026 5-year trend
SG&A Expense
449.12M 472.89M 482.71M 482.83M
Research & Development
- - - -
-
Other SG&A
449.12M 472.89M 482.71M 482.83M
SGA Growth
+6.27% +5.29% +2.08% +0.02%
Other Operating Expense
- - - -
-
Unusual Expense
- 4.69M 26.28M 27.47M
EBIT after Unusual Expense
224.98M 158.76M 51.03M 75.71M
Non Operating Income/Expense
(10.59M) (1.51M) 765.40K 5.23M
Non-Operating Interest Income
2.29M 3.77M 4.85M 4.96M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
22.51M 40.44M 40.57M 37.12M
Interest Expense Growth
+9.87% +79.67% +0.30% -8.49%
Gross Interest Expense
22.51M 40.44M 40.57M 37.12M
Interest Capitalized
- - - -
-
Pretax Income
191.88M 116.81M 11.23M 43.82M
Pretax Income Growth
-34.45% -39.12% -90.39% +290.35%
Pretax Margin
+15.94% +10.60% +1.12% +4.28%
Income Tax
36.71M 29.89M 5.49M 11.93M
Income Tax - Current - Domestic
31.78M 20.85M 2.04M 9.92M
Income Tax - Current - Foreign
5.18M 8.04M 4.85M 4.29M
Income Tax - Deferred - Domestic
(240.75K) 1.00M (1.40M) (2.28M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
155.16M 86.92M 5.74M 31.89M
Minority Interest Expense
- - - -
-
Net Income
155.16M 86.92M 5.74M 31.89M
Net Income Growth
-37.31% -43.98% -93.40% +455.59%
Net Margin Growth
+12.89% +7.89% +0.57% +3.11%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
155.16M 86.92M 5.74M 31.89M
Preferred Dividends
- - - -
-
Net Income Available to Common
155.16M 86.92M 5.74M 31.89M
EPS (Basic)
0.1551 0.0884 0.006 0.0331
EPS (Basic) Growth
-37.33% -43.00% -93.21% +451.67%
Basic Shares Outstanding
1.00B 983.50M 962.30M 964.70M
EPS (Diluted)
0.155 0.0882 0.0059 0.0326
EPS (Diluted) Growth
-37.20% -43.10% -93.31% +452.54%
Diluted Shares Outstanding
1.00B 985.60M 974.10M 979.60M
EBITDA
294.92M 249.57M 170.05M 195.25M
EBITDA Growth
-19.85% -15.38% -31.86% +14.82%
EBITDA Margin
+24.49% +22.65% +16.92% +19.05%

Dr. Martens Plc in the News